Gevo Granted Critical Patent Enabling Commercially Viable Yields of Isobutanol Production from Yeast

Gevo, Inc. GEVO announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,153,415 entitled “Reduced By-Product Accumulation for Improved Production of Isobutanol.” The ‘415 Patent covers technology which eliminates two pathways that compete for isobutanol pathway intermediates in yeast. The claimed modifications helped Gevo create a more efficient isobutanol-producing yeast.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!